Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017

We investigated the epidemiology of extrapulmonary tuberculosis (TB) among patients admitted to Beijing Chest Hospital, Beijing, China, during January 2008–December 2017. Of 19,279 hospitalized TB patients, 33.4% (6,433) had extrapulmonary TB and 66.6% (12,846) had pulmonary TB. The most frequent fo...

Full description

Bibliographic Details
Main Authors: Yu Pang, Jun An, Wei Shu, Fengmin Huo, Naihui Chu, Mengqiu Gao, Shibing Qin, Hairong Huang, Xiaoyou Chen, Shaofa Xu
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2019-03-01
Series:Emerging Infectious Diseases
Subjects:
TB
Online Access:https://wwwnc.cdc.gov/eid/article/25/3/18-0572_article
id doaj-51fce38361fc43eb8d8493d3e32c1268
record_format Article
spelling doaj-51fce38361fc43eb8d8493d3e32c12682020-11-25T01:11:55ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592019-03-0125345746410.3201/eid2503.180572Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017Yu PangJun AnWei ShuFengmin HuoNaihui ChuMengqiu GaoShibing QinHairong HuangXiaoyou ChenShaofa XuWe investigated the epidemiology of extrapulmonary tuberculosis (TB) among patients admitted to Beijing Chest Hospital, Beijing, China, during January 2008–December 2017. Of 19,279 hospitalized TB patients, 33.4% (6,433) had extrapulmonary TB and 66.6% (12,846) had pulmonary TB. The most frequent forms of extrapulmonary TB observed were skeletal TB (41.1%) and pleural TB (26.0%). Younger, female patients from rural areas were more likely to have extrapulmonary TB. However, patients with diabetes mellitus were less likely to have extrapulmonary TB compared with patients without diabetes. A higher proportion of multidrug-resistant (MDR) TB was observed among patients with extrapulmonary TB than among patients with pulmonary TB. We observed a large increase in MDR TB, from 17.3% to 35.7%, for pleural TB cases. The increasing rate of drug resistance among extrapulmonary TB cases highlights the need for drug susceptibility testing and the formulation of more effective regimens for extrapulmonary TB treatment. https://wwwnc.cdc.gov/eid/article/25/3/18-0572_articletuberculosisextrapulmonarydrug resistancerisk factorChinaTB
collection DOAJ
language English
format Article
sources DOAJ
author Yu Pang
Jun An
Wei Shu
Fengmin Huo
Naihui Chu
Mengqiu Gao
Shibing Qin
Hairong Huang
Xiaoyou Chen
Shaofa Xu
spellingShingle Yu Pang
Jun An
Wei Shu
Fengmin Huo
Naihui Chu
Mengqiu Gao
Shibing Qin
Hairong Huang
Xiaoyou Chen
Shaofa Xu
Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017
Emerging Infectious Diseases
tuberculosis
extrapulmonary
drug resistance
risk factor
China
TB
author_facet Yu Pang
Jun An
Wei Shu
Fengmin Huo
Naihui Chu
Mengqiu Gao
Shibing Qin
Hairong Huang
Xiaoyou Chen
Shaofa Xu
author_sort Yu Pang
title Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017
title_short Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017
title_full Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017
title_fullStr Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017
title_full_unstemmed Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017
title_sort epidemiology of extrapulmonary tuberculosis among inpatients, china, 2008–2017
publisher Centers for Disease Control and Prevention
series Emerging Infectious Diseases
issn 1080-6040
1080-6059
publishDate 2019-03-01
description We investigated the epidemiology of extrapulmonary tuberculosis (TB) among patients admitted to Beijing Chest Hospital, Beijing, China, during January 2008–December 2017. Of 19,279 hospitalized TB patients, 33.4% (6,433) had extrapulmonary TB and 66.6% (12,846) had pulmonary TB. The most frequent forms of extrapulmonary TB observed were skeletal TB (41.1%) and pleural TB (26.0%). Younger, female patients from rural areas were more likely to have extrapulmonary TB. However, patients with diabetes mellitus were less likely to have extrapulmonary TB compared with patients without diabetes. A higher proportion of multidrug-resistant (MDR) TB was observed among patients with extrapulmonary TB than among patients with pulmonary TB. We observed a large increase in MDR TB, from 17.3% to 35.7%, for pleural TB cases. The increasing rate of drug resistance among extrapulmonary TB cases highlights the need for drug susceptibility testing and the formulation of more effective regimens for extrapulmonary TB treatment.
topic tuberculosis
extrapulmonary
drug resistance
risk factor
China
TB
url https://wwwnc.cdc.gov/eid/article/25/3/18-0572_article
work_keys_str_mv AT yupang epidemiologyofextrapulmonarytuberculosisamonginpatientschina20082017
AT junan epidemiologyofextrapulmonarytuberculosisamonginpatientschina20082017
AT weishu epidemiologyofextrapulmonarytuberculosisamonginpatientschina20082017
AT fengminhuo epidemiologyofextrapulmonarytuberculosisamonginpatientschina20082017
AT naihuichu epidemiologyofextrapulmonarytuberculosisamonginpatientschina20082017
AT mengqiugao epidemiologyofextrapulmonarytuberculosisamonginpatientschina20082017
AT shibingqin epidemiologyofextrapulmonarytuberculosisamonginpatientschina20082017
AT haironghuang epidemiologyofextrapulmonarytuberculosisamonginpatientschina20082017
AT xiaoyouchen epidemiologyofextrapulmonarytuberculosisamonginpatientschina20082017
AT shaofaxu epidemiologyofextrapulmonarytuberculosisamonginpatientschina20082017
_version_ 1725168925706027008